Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.

Benzer Materyaller

• Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
  Yazar:: Hsieh, Chen-Hsi, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part
  Yazar:: Vermorken, J B, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squamous Cell Head and Neck Cancer
  Yazar:: Cohen, Martin H., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma
  Yazar:: Adkins, Douglas, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck
  Yazar:: Pendleton, Kelsey P., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)